Hepatitis B reactivation and rituximab in the oncology practice.

Hepatitis B reactivation and rituximab in the oncology practice.

Item
http://www.wikidata.org/entity/Q35583718
Hepatitis B virus management to prevent reactivation after chemotherapy: a review.Current and emerging monoclonal antibody treatments for chronic lymphocytic leukemia: state of the art.Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center.A 60-year-old Indian male with altered sensorium and extensive lymphoma of the scalpPatients with hematological malignancies and serological signs of prior resolved hepatitis B.Stopping Preemptive Antiviral Therapy for Hepatitis B Virus Can Be Considered for Patients with Favorable Predictors.Bortezomib monotherapy in patients with multiple myeloma is associated with reactivation of hepatitis B.Fatal Fulminant Hepatitis from Rituximab-induced Hepatitis B Reactivation in a Patient with Follicular Lymphoma: A Case Report and a Brief Review of Literature.
P2860

Hepatitis B reactivation and rituximab in the oncology practice.

Item
http://www.wikidata.org/entity/Q35583718
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Hepatitis B reactivation and rituximab in the oncology practice.
@ast
Hepatitis B reactivation and rituximab in the oncology practice.
@en
type
label
Hepatitis B reactivation and rituximab in the oncology practice.
@ast
Hepatitis B reactivation and rituximab in the oncology practice.
@en
prefLabel
Hepatitis B reactivation and rituximab in the oncology practice.
@ast
Hepatitis B reactivation and rituximab in the oncology practice.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Hepatitis B reactivation and rituximab in the oncology practice
@en
P2093
P2860
P304
P31
P356
10.1634/THEONCOLOGIST.2010-0106
P433
P478
P50
P577
P5875
P698
P932